Matthew Miessau is an Associate with Epidarex Capital, a Bethesda-based venture capital firm which finds, invests in, and builds early-stage breakthrough life sciences companies in emerging hubs. Mr. Miessau is also currently an instructor at the NIH Foundation for Advanced Education in the Sciences (FAES), teaching Biomedical Business Development for Scientists. Prior to joining Epidarex, he was the Program Manager for the Georgetown University Center for Drug Discovery. Mr. Miessau holds an M.S. in biotechnology and a B.S. in biochemistry from Georgetown University.